Skip to main content
. 2018 May 22;2018(5):CD011977. doi: 10.1002/14651858.CD011977.pub2

Schmoll 2014.

Methods Study design: RCT
Study grouping: parallel group, with one eye per participant randomised to one of the interventions
Exclusions after randomisation: in all, 108 participants were recruited (including 21 age‐matched "control" participants, who did not receive an IOL and were not included these analyses), of whom 80 completed the study. Of the 28 who did not, 26 voluntarily declined to attend for the second test appointment, one had uncontrolled glaucoma and one required intercurrent hospital admission for an exacerbation of chronic obstructive pulmonary disease.
Losses to follow‐up: as described above
How missing data were handled: not reported
Reported power size calculation? no
Participants Baseline characteristics
Blue‐light filtering IOL group
  • Number of participants: number of people (number of eyes): 19 (19)

  • Sex (number of women/number of men): not reported

  • Age (mean ± unit of error): not reported


Non‐blue‐light filtering IOL group
  • Number of participants: number of people (number of eyes): 40 (40)

  • Sex (number of women/number of men): not reported

  • Age (mean ± unit of error): not reported


Inclusion criteria: participants were voluntarily recruited from routine cataract assessment clinics after providing informed consent. Participants were included regardless of whether they were being assessed for first‐ or second‐eye cataract surgery, or as controls.
Exclusion criteria: participants unable to read the N48 test display on the reaction time task, those diagnosed with Parkinson’s Disease or dementia, any intercurrent illness requiring hospital admission, any previous ophthalmic history involving retinal damage including proliferative diabetic retinopathy, diabetic macular oedema, exudative AMD, central retinal artery or vein occlusion, and retinal detachment surgery.
Comparison of study groups at baseline: not reported
Interventions Intervention characteristics
Blue‐light filtering IOL
  • Type of IOL: AcrySof SN60 WF (Alcon)


Non‐blue‐light filtering IOL
  • Type of IOL: Tecnis ZCB00 (AMO)

Outcomes Choice reaction time (CRT) and the Epworth Sleepiness Score (ESS), at three months postoperatively
Identification Sponsorship source:
Funding sources: not commissioned
Declaration of interest: no competing interests
Country: Scotland
Setting: St Johns Hospital, Livingston, United Kingdom
Comments:
Date study conducted: not reported
Trial registration number: not reported
Contacting study investigators: study authors not contacted; no additional information used for review
First author's name: Dr Conrad Schmoll
Institution: Princess Alexandra Eye Pavilion
Email: conradschmoll@gmail.com
Corresponding author's address:
Conrad Schmoll
Princess Alexandra Eye Pavilion
45 Chalmers Street, Edinburgh EH3 9HA, UK
Notes None
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "prospective randomised"
Judgement comment: not reported how list was generated. Study is described as “randomised” but with no further details
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported how allocation administered. Study is described as “randomised” but with no further details
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "Participants undergoing first‐eye cataract surgery were randomised to receive either a blue‐blocking IOL (Alcon Acrysof SN60WF) or a UV‐blocking IOL (AMO Tecnis ZCB00), and were masked as to which IOL type had been implanted. Study protocol dictated that participants undergoing second‐eye cataract surgery would receive an identical lens to their previous one. These patients had not been issued with information cards after their first‐eye surgery and were therefore unaware of which lens type they received."
Judgement comment: participants were reported to be masked; although personnel were reported to be masked, this is not anticipated to significantly affect the study outcomes as most outcome measures were participant‐reported.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Judgement comment: unclear whether outcome assessors were masked
Incomplete outcome data (attrition bias) 
 All outcomes High risk Quote: "108 participants were recruited, of whom 80 completed the study. Of the 28 who did not, 26 voluntarily declined to attend for the second test appointment, one had uncontrolled glaucoma and one required intercurrent hospital admission for an exacerbation of chronic obstructive pulmonary disease."
Judgement comment: overall follow‐up < 80%, and follow‐up in each group not reported
Selective reporting (reporting bias) Unclear risk Judgement comment: no access to protocol or trials registry entry
Other bias Low risk Judgement comment: no other apparent sources of bias